Cholangiocarcinoma: Causes, Symptoms & Treatment

What is Cholangiocarcinoma?

Cholangiocarcinoma is a malignant (cancerous) tumor that originates from the epithelial cells lining the bile ducts. The bile ducts are tube-like structures that carry bile produced by the liver into the small intestine. Depending on the location of the tumor, cholangiocarcinoma is classified into three types: intrahepatic cholangiocarcinoma (arising within the liver), perihilar cholangiocarcinoma (at the junction of the major bile ducts, also known as a Klatskin tumor), and distal cholangiocarcinoma (in the lower portion of the bile duct). It is a rare but aggressive cancer with an increasing global incidence.

Causes and Risk Factors

The exact cause of cholangiocarcinoma is often not clearly identifiable. However, several factors are known to increase the risk:

• Primary Sclerosing Cholangitis (PSC): A chronic inflammatory condition causing scarring of the bile ducts is the most significant risk factor in Western countries.
• Liver flukes: Infections with parasitic liver flukes (e.g., Opisthorchis viverrini) are a common cause in Southeast Asia.
• Chronic liver disease: Liver cirrhosis, viral hepatitis B and C, and non-alcoholic fatty liver disease all increase risk.
• Choledochal cysts: Congenital dilations of the bile duct.
• Bile duct stones (choledocholithiasis): Long-term irritation of the bile duct lining.
• Exposure to certain chemicals: Substances such as thorotrast or dioxins are considered carcinogenic.
• Advanced age: Most patients are older than 65 years at diagnosis.

Symptoms

Cholangiocarcinoma often causes no or only vague symptoms in its early stages, which makes timely diagnosis challenging. Common symptoms in advanced stages include:

• Jaundice (icterus): Yellowing of the skin and eyes due to bile backflow.
• Dark urine and pale stools: Also a result of bile duct obstruction.
• Itching (pruritus): Caused by bile salts circulating in the bloodstream.
• Upper abdominal pain: A dull ache in the right upper abdomen.
• Unexplained weight loss and loss of appetite.
• Fatigue and general weakness.
• Fever: May indicate an associated bile duct infection (cholangitis).

Diagnosis

Diagnosing cholangiocarcinoma requires a combination of investigations:

Blood Tests

Laboratory values may indicate bile duct obstruction (elevated bilirubin, alkaline phosphatase, gamma-GT). Tumor markers such as CA 19-9 and CEA may be elevated but are not specific enough for a definitive diagnosis on their own.

Imaging Studies

• Ultrasound (sonography): Typically the first investigation when cholangiocarcinoma is suspected.
• Computed Tomography (CT) and Magnetic Resonance Imaging (MRI): Provide detailed images of the bile ducts and surrounding structures.
• MRCP (Magnetic Resonance Cholangiopancreatography): A specialized MRI technique for precise visualization of the bile ducts.
• ERCP (Endoscopic Retrograde Cholangiopancreatography): Allows both diagnosis and therapeutic interventions (e.g., stent placement).
• PET-CT: Used to assess for distant metastases.

Tissue Biopsy

A definitive diagnosis typically requires a tissue sample for histological examination, which can be obtained via ERCP, percutaneous biopsy, or during surgery.

Treatment

Treatment of cholangiocarcinoma depends on the location and stage of the tumor as well as the overall condition of the patient.

Surgery

Surgical resection is the only potentially curative treatment. The goal is complete removal of the tumor with adequate margins. Depending on tumor location, this may involve partial liver removal (hemihepatectomy), removal of the bile ducts, or a combination of both. Unfortunately, surgery is only possible in a minority of patients because the tumor is often discovered at an advanced stage.

Liver Transplantation

In highly selected cases of early-stage perihilar cholangiocarcinoma, liver transplantation may be considered as a treatment option.

Chemotherapy

The standard chemotherapy regimen for unresectable tumors consists of gemcitabine and cisplatin. Recent studies have shown that the addition of durvalumab (an immune checkpoint inhibitor) improves overall survival.

Targeted Therapy

Molecular profiling of the tumor can identify specific genetic alterations for which targeted drugs are available, such as IDH1 inhibitors (e.g., ivosidenib) or FGFR2 inhibitors (e.g., pemigatinib).

Radiation Therapy

Radiotherapy may be used in selected situations, for example for pain relief or as an adjunct after surgery.

Palliative Care

When the disease cannot be cured, the focus shifts to improving quality of life. Bile duct drainage via stent placement is a key palliative measure to restore bile flow and relieve symptoms such as jaundice and itching.

Prognosis

The prognosis of cholangiocarcinoma depends strongly on the stage at diagnosis. Since most cases are detected at an advanced stage, the overall outlook is poor. However, when a tumor is detected early and completely removed surgically, genuine chances of cure exist. Regular follow-up examinations and close monitoring by a specialized multidisciplinary team are essential for all patients.

References

1. Banales J.M. et al. - Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nature Reviews Gastroenterology & Hepatology, 2020.
2. European Association for the Study of the Liver (EASL) - EASL-ESMO Clinical Practice Guidelines for the diagnosis and treatment of iCCA, pCCA and dCCA, 2023.
3. National Cancer Institute (NCI) - Bile Duct Cancer (Cholangiocarcinoma) Treatment (PDQ). Available at: www.cancer.gov.